Amylyx Pharmaceuticals, Inc. (AMLX)
38.14
-0.52
(-1.35%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Liabilities (Quarterly) : 25.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.40M |
| March 31, 2026 | 20.44M |
| December 31, 2025 | 28.82M |
| September 30, 2025 | 30.74M |
| June 30, 2025 | 26.72M |
| March 31, 2025 | 18.26M |
| December 31, 2024 | 28.87M |
| September 30, 2024 | 54.51M |
| June 30, 2024 | 70.85M |
| March 31, 2024 | 93.02M |
| December 31, 2023 | 84.02M |
| September 30, 2023 | 48.18M |
| Date | Value |
|---|---|
| June 30, 2023 | 67.22M |
| March 31, 2023 | 55.31M |
| December 31, 2022 | 50.85M |
| September 30, 2022 | 37.42M |
| June 30, 2022 | 32.45M |
| March 31, 2022 | 33.49M |
| December 31, 2021 | 17.43M |
| September 30, 2021 | 15.18M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 8.767M |
| September 30, 2020 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
| EyePoint, Inc. | 61.78M |
| Bristol Myers Squibb Co. | 65.32B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.56M |
| Shareholders Equity (Quarterly) | 239.17M |
| Debt to Equity Ratio | 0.022 |
| Current Ratio | 12.12 |
| Net Debt Paydown Yield | -0.04% |